SARS-CoV-2 Main Protease Inhibitors: Structure-Based Enhancement to Anti-Viral Pre-Clinical GC376 Encourages Further Development

Overview of attention for article published in Journal of Computational Biophysics and Chemistry, February 2023

Altmetric Badge

Mentioned by

twitter: 8 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 15,391 followers.

Well done Yao and Simon!

07 Jun 2023

Reply Repost Favourite

📜New paper alert! Congratulations🎉 to Yao Zu and Simon Chapman, whose paper with a former Master student (Elliot Perry) has now been published Read more about SARS-CoV-2 protease inhibitors here 👉🏿https://t.co/6fHVjk8Yey

07 Jun 2023

Reply Repost Favourite

RT @WSJCBC: Researchers from @OU_chemistry selected @AniviveLifeSci's antiviral GC376 as scaffold to design new SARS-CoV-2 main protease (M…

12 Feb 2023

Reply Repost Favourite

RT @WSJCBC: Researchers from @OU_chemistry selected @AniviveLifeSci's antiviral GC376 as scaffold to design new SARS-CoV-2 main protease (M…

12 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.